Literature DB >> 15561147

Human deoxycytidine kinase as a deoxyribonucleoside phosphorylase.

Elena Usova1, Tatiana Maltseva, András Földesi, Jyoti Chattopadhayaya, Staffan Eriksson.   

Abstract

Human deoxycytidine kinase (dCK) is a key enzyme in the 5'-phosphorylation of purine and pyrimidine deoxynucleosides with deoxycytidine as the most efficient substrate. The ability of dCK to degrade 2'-deoxyribonucleosides to free nucleobases and 2-deoxy-alpha-d-ribofuranose-1-phosphate was demonstrated by 1H-31P correlation spectroscopy and by isotope enzyme kinetic methods. The reaction depended on inorganic phosphate, and dCK showed maximum cleavage activity between pH 7 and pH 8. In this pH range, [HPO4(2-)] is the dominant phosphate species, most likely being the phosphate donor. All natural deoxyribonucleosides could be cleaved and the Vmax of the phosphorylytic reaction compared to the kinase reaction was about 2-10%. The formation of free nucleobases occurred only with reduced dCK, because the reaction was highly dependent on the presence of reducing agents such as dithiotreitol. Thus, recombinant dCK can act as a phosphorylase, similar to the nucleoside phosphorylase family of enzymes. This catalytic activity is important for the design of in vitro experiments with dCK, such as crystallization and NMR spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561147     DOI: 10.1016/j.jmb.2004.10.016

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  3 in total

1.  Biosynthesis of albomycin δ(2) provides a template for assembling siderophore and aminoacyl-tRNA synthetase inhibitor conjugates.

Authors:  Yu Zeng; Aditya Kulkarni; Zhaoyong Yang; Preeti B Patil; Wei Zhou; Xiuling Chi; Steven Van Lanen; Shawn Chen
Journal:  ACS Chem Biol       Date:  2012-06-25       Impact factor: 5.100

2.  Fast metabolic response to drug intervention through analysis on a miniaturized, highly integrated molecular imaging system.

Authors:  Jun Wang; Kiwook Hwang; Daniel Braas; Alex Dooraghi; David Nathanson; Dean O Campbell; Yuchao Gu; Troy Sandberg; Paul Mischel; Caius Radu; Arion F Chatziioannou; Michael E Phelps; Heather Christofk; James R Heath
Journal:  J Nucl Med       Date:  2013-08-26       Impact factor: 10.057

3.  New trends in nucleoside biotechnology.

Authors:  I A Mikhailopulo; A I Miroshnikov
Journal:  Acta Naturae       Date:  2010-07       Impact factor: 1.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.